Application no. and date | 10733117.5 (espacenet) (Federated) (European Patent Register), 20100712 | Patent/reg. no. and date | DK/EP 2454275, 20170712 | Publication date | 20120523 | Priority no. and date | US 502181, 20090713 | EP pub. no. and date |
EP 2454275 20120523 | Effective date | | Applicant/owner | ALLERGAN, INC., 2525 Dupont Drive
Irvine CA 92612, US | Applicant ref. no. | P62672DK01 | Inventor | TON, Jennifer L., 3595 Sego Street
Irvine California 92606, US, PATEL, Hemant A., 12 Twilight Lane
Rancho Santa Margarita California 92688, US, BATES, Ronald C., 457 Shadow Oaks
Irvine California 92618, US, AHMAD, Wajdie M., 2103 Anacapa
Irvine California 92602, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 38/16 (2006.01) , C07K 14/33 (2006.01) , C12N 1/20 (2006.01) , C12P 21/02 (2006.01) | Title | FREMGANGSMÅDE OG SYSTEM TIL OPNÅELSE AF BOTULINUM-NEUROTOKSIN | Int. application no. | US2010041745 | Int. publication no. | WO2011008713 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|